Abortion reporting in the era of medical procedures: why is it important?
Food and Drug Administration approval of mifepristone and the subsequent widespread use of medical abortion will change the patterns and practice of abortion services in this country. Accurate monitoring of new, nonsurgical abortion techniques will be critical as this change takes place. Providers will want to know which women will be the predominant users of medical versus surgical methods. If medical procedures are used widely, the national trend in gestational age at the time of abortion is likely to change because medical procedures are usually performed early (at less than eight weeks' gestation). New and existing abortion providers must be informed about the reporting statutes and requirements in their areas. Information and instructions for reporting abortions are available from the vital statistics offices in each state health department and the health departments of New York City and the District of Columbia. Ongoing comprehensive monitoring of legal induced abortion is needed in all states to determine the number of procedures performed, the characteristics of women who obtain them, and the evolving trends in procedures.
Koonin
L M
LM
Surveillance Unit, Centers for Disease Control and Prevention, Atlanta, USA.
D000021:Abortifacient Agents, Steroidal / Q000008:administration & dosage*; D000028:Abortion, Induced / Q000379:methods / Q000706:statistics & numerical data* / Q000639:trends; D003625:Data Collection; D005260:Female; D006801:Humans; D007255:Information Services; D015735:Mifepristone / Q000008:administration & dosage*; D011247:Pregnancy; D011264:Pregnancy Trimesters; D014481:United States; D014798:Vital Statistics
D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone